Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masaichi Yamamoto is active.

Publication


Featured researches published by Masaichi Yamamoto.


Veterinary Microbiology | 1987

Cell-mediated and humoral immune response to non-viable Mycoplasma pulmonis in mice enhanced by cross-linked ricin

Masato Kishima; Chikara Kuniyasu; Masaichi Yamamoto; Eisei Imamura

The enhancing effect of cross-linked ricin (CL-ricin) on the cell-mediated and humoral immune response of mice to non-viable Mycoplasma pulmonis was studied. The cell-mediated immune response was evaluated by means of the delayed-type footpad swelling, and the humoral immune response by means of the indirect hemagglutination test. Mice pre-treated subcutaneously with non-viable M. pulmonis and CL-ricin showed significantly increased delayed-type footpad swelling when they were injected in the footpad with the same antigen 7 days later. Delayed-type footpad swelling was not detected in mice pre-treated only with non-viable M. pulmonis or CL-ricin followed by footpad injection with non-viable M. pulmonis. Injection of non-viable M. pulmonis in the footpad on Days 3, 7, 14, 21, 28, 35 and 42 after pre-treatment with non-viable M. pulmonis and CL-ricin resulted in significant footpad swelling. Delayed-type footpad swelling was transferred by intravenous injection of spleen cells from mice which had been pre-treated 7 days previously with non-viable M. pulmonis and CL-ricin into non-treated recipient mice. Intravenous injection of anti-mouse thymus cell serum into mice previously pre-treated with non-viable M. pulmonis and CL-ricin reduced the delayed-type footpad swelling significantly. Mice pre-treated subcutaneously with non-viable M. pulmonis and CL-ricin showed a marked increase in serum antibody titers compared with those that received non-viable M. pulmonis alone.


Archive | 1981

Milk-claw including inspection means for milk sucked from cow's teats

Shoetsu Fukuhara; Yoshiaki Nakamura; Tadahiro Ibuki; Masaichi Yamamoto


Archive | 1996

β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound

Masaichi Yamamoto; Seiichi Araki; Hiroshi Yamamoto; Isao Yamatsu; Takeshi Suzuki; Akiharu Kajiwara; Yoshikazu Suzuki; Haruyoshi Arai


Archive | 1985

Composition for prevention and treatment of mycoplasmal pneumonia

Masaichi Yamamoto; Hiroshi Yamamoto


Archive | 1983

ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung

Masaichi Yamamoto; Seiichi Araki; Hiroshi Yamamoto; Isao Yamatsu; Takeshi Suzuki; Akiharu Kajiwara; Yoshikazu Suzuki; Haruyoshi Arai


Archive | 1997

β, γ-dihydropolyprenyl alcohol derivatives effective at mitigating stress in animals

Masaichi Yamamoto; Seiichi Araki; Hiroshi Yamamoto; Isao Yamatsu; Takeshi Suzuki; Akiharu Kajiwara; Yoshikazu Suzuki; Haruyoshi Arai


Archive | 1983

Ss,(gamma)-dihydropolyprenylalkoholderivate und arzneimittel, welche diese enthalten

Masaichi Yamamoto; Seiichi Araki; Hiroshi Yamamoto; Isao Yamatsu; Takeshi Suzuki; Akiharu Kajiwara; Yoshikazu Suzuki; Haruyoshi Arai


Archive | 1988

MILKING MACHINE; TEAT CUP PULSATIONS HALTED WHEN MILK FLOW CEASES

Tadaaki Tanaka; Tadahiro Ibuki; Yoshiaki Nakamura; Masaichi Yamamoto


Archive | 1983

A pharmaceutical composition comprising as active principle docosanol

Masaichi Yamamoto; Seiichi Araki; Hiroshi Yamamoto; Isao Yamatsu; Akiharu Kajiwara; Yoshikazu Suzuki; Haruyoshi Arai; Takeshi Suzuki


Archive | 1983

Ss,(gamma)-dihydropolyprenylalkoholderivate und arzneimittel, welche diese enthalten Ss, (gamma) -dihydropolyprenylalkoholderivate and pharmaceutical compositions containing these

Masaichi Yamamoto; Seiichi Araki; Hiroshi Yamamoto; Isao Yamatsu; Takeshi Suzuki; Akiharu Kajiwara; Yoshikazu Suzuki; Haruyoshi Arai

Researchain Logo
Decentralizing Knowledge